Asthma Mild Moderate Severe

Nirmatrelvir-Ritonavir Reduces Long COVID Risk in Older Adults, Not Adolescents

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.

一些您可能无法访问的结果已被隐去。